These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1885634)

  • 1. Darwin Lecture. Development of controlled trials in preventive and therapeutic medicine.
    Doll R
    J Biosoc Sci; 1991 Jul; 23(3):365-78. PubMed ID: 1885634
    [No Abstract]   [Full Text] [Related]  

  • 2. UK Medical Research Council and multicentre clinical trials: from a damning report to international recognition.
    Chalmers I
    J R Soc Med; 2013 Dec; 106(12):498-509. PubMed ID: 24284996
    [No Abstract]   [Full Text] [Related]  

  • 3. Memories of the 1953-54 Oxygen Trial and its aftermath. The failure of success.
    Silverman WA
    Control Clin Trials; 1991 Jun; 12(3):355-8. PubMed ID: 1651206
    [No Abstract]   [Full Text] [Related]  

  • 4. Controlled trials: the 1948 watershed.
    Doll R
    BMJ; 1998 Oct; 317(7167):1217-20. PubMed ID: 9794864
    [No Abstract]   [Full Text] [Related]  

  • 5. The social history of ISIS-2: triumph and the path not taken.
    Keating C
    Lancet; 2015 Aug; 386(9994):e4-5. PubMed ID: 26334164
    [No Abstract]   [Full Text] [Related]  

  • 6. Interferon beta-lb is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. 1993 [classical article].
    IFNB Multiple Sclerosis Study Group
    Neurology; 2001 Dec; 57(12 Suppl 5):S3-9. PubMed ID: 11902592
    [No Abstract]   [Full Text] [Related]  

  • 7. Cooperative group trials in pediatric oncology: the surgeon's role.
    Shamberger RC
    J Pediatr Surg; 2013 Jan; 48(1):1-13. PubMed ID: 23331786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind, placebo-controlled trial. 1995.
    Johnson KP; Brooks BR; Cohen JA; Ford CC; Goldstein J; Lisak RP; Myers LW; Panitch HS; Rose JW; Schiffer RB; Vollmer T; Weiner LP; Wolinsky JS;
    Neurology; 2001 Dec; 57(12 Suppl 5):S16-24. PubMed ID: 11902590
    [No Abstract]   [Full Text] [Related]  

  • 9. Richard Cabot, pair-matched random allocation, and the attempt to compare like with like in the social sciences and medicine. Part 1: the context of the social sciences.
    Welsh BC; Podolsky SH; Zane SN
    J R Soc Med; 2021 Apr; 114(4):212-217. PubMed ID: 33899593
    [No Abstract]   [Full Text] [Related]  

  • 10. Interferon beta-lb is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. 1993 [classical article].
    Paty DW; Li DK;
    Neurology; 2001 Dec; 57(12 Suppl 5):S10-5. PubMed ID: 11902589
    [No Abstract]   [Full Text] [Related]  

  • 11. Establishing the experimenting society: the historical origin of social experimentation according to the randomized controlled design.
    Dehue T
    Am J Psychol; 2001; 114(2):283-302. PubMed ID: 11430152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Commentary: the 1944 patulin trial: the first properly controlled multicentre trial conducted under the aegis of the British Medical Research Council.
    Chalmers I; Clarke M
    Int J Epidemiol; 2004 Apr; 33(2):253-60. PubMed ID: 15082623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [50 years of clinical trials; a new direction in medicine].
    Van Gijn J
    Ned Tijdschr Geneeskd; 1999 Jan; 143(1):1-3. PubMed ID: 10086087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized controlled trials mark a golden anniversary.
    Randal J
    J Natl Cancer Inst; 1999 Jan; 91(1):10-2. PubMed ID: 9890163
    [No Abstract]   [Full Text] [Related]  

  • 15. The science and ethics of the randomized clinical trial.
    Bleich HL
    MD Comput; 1995; 12(1):5-6. PubMed ID: 7854079
    [No Abstract]   [Full Text] [Related]  

  • 16. Powerful placebo: the dark side of the randomised controlled trial.
    Kaptchuk TJ
    Lancet; 1998 Jun; 351(9117):1722-5. PubMed ID: 9734904
    [No Abstract]   [Full Text] [Related]  

  • 17. Fisher, Bradford Hill, and randomization.
    Armitage P
    Int J Epidemiol; 2003 Dec; 32(6):925-8; discussion 945-8. PubMed ID: 14681247
    [No Abstract]   [Full Text] [Related]  

  • 18. Fisher and Bradford Hill: their personal impact.
    Doll R
    Int J Epidemiol; 2003 Dec; 32(6):929-31; discussion 945-8. PubMed ID: 14681248
    [No Abstract]   [Full Text] [Related]  

  • 19. John Geddes: design for life.
    Holmes D
    Lancet; 2014 Oct; 384(9953):1495. PubMed ID: 25390566
    [No Abstract]   [Full Text] [Related]  

  • 20. Double-blind trial of recombinant gamma-interferon versus placebo in the treatment of rheumatoid arthritis. 1989.
    Cannon GW; Pincus SH; Emkey RD; Denes A; Cohen SA; Wolfe F; Saway PA; Jaffer AM; Weaver AL; Cogen L; Schindler JD
    Arthritis Rheum; 2008 Feb; 58(2 Suppl):S79-88. PubMed ID: 18240222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.